Navigating Cancer Immunotherapy: Exploring the World of mRNA Vaccines
Vložit
- čas přidán 28. 02. 2024
- CRI’s Cancer Immunotherapy and YouTM Patient Education Webinar Series returns with its latest offering, “Navigating Cancer Immunotherapy: Exploring the World of Cancer Vaccines.”
Featuring Dr. Vinod Balachandran from Memorial Sloan Kettering Cancer Center, the webinar sheds light on the recent advances in vaccine development and explains how different types of cancer vaccines. Join us as Dr. Balachandran explains how developing cancer vaccines can change the face of cancer therapy.
Established in 1953, the Cancer Research Institute (CRI) is a 501(c)(3) nonprofit organization dedicated to harnessing our immune system’s power to control and potentially cure all cancers. Our mission: Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. To accomplish this, we rely on donor support and collaborative partnerships to fund and carry out the most innovative clinical and laboratory research around the world, support the next generation of the field’s leaders, and serve as the trusted source of information on immunotherapy for cancer patients and their caregivers. www.cancerresearch.org
Cancer Research Institute is a registered 501(c)(3) nonprofit under EIN 13-1837442. Donations are tax-deductible to the fullest extent allowable under the law.
Excellent discussion of cancer immunotherapy. Looking forward to the continued research and development of targeted and immunotherapies. We also need to emphasize prevention and early detection as part of our collective health care goals. As a semi-retired radiation oncologist, I have witnessed remarkable responses in my own patients who received targeted therapies and/or immunotherapies. As a patient, the prospect of vaccines to treat cancers holds hope for many of us. GJBrownDO 5/24/2024 06:05 Pacific
Thanks for watching!
Blood cancer has a lot of mutations.Perhaps it can be targeted with vaccines,Cll,MM ect.